NEWHALL CHARLES W III received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2026ACC: 0001005544-26-000004
Director
Since Feb 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
4.47K acquired · 4.47K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.47K
Price / share
—
Trade value
—
% of position
3.7%
2/24/2026
119.64K→124.12K
Total
Net shares
+4.47K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | A · Award | +4.47K | — | — | 3.7% | 119.64K | 124.12K |
| Total | +4.47K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
4.47K shares
Shares
−4.47K
Strike price
Held after
0.00
Exercisable
—
2/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock4.47K shares | 2/24/2026 | D · Disposition | −4.47K | — | 0.00 |